AbbVie | ABBV - Trade Debtors



AbbVie reported $12.48B in Trade Debtors for its fiscal quarter ending in March of 2025.


Trade Debtors Change Date
AbbVie USD 12.48B 1.56B Mar/2025
Abbott USD 10.23B 562M Jun/2025
ALKERMES USD 356.33M 34.58M Jun/2025
Amgen USD 8.7B 569M Jun/2025
AstraZeneca USD 16.24B 1.42B Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Eisai JPY 219.98B 42M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
GlaxoSmithKline GBP 7.7B 196M Jun/2025
J&J USD 16.02B 1.18B Mar/2025
Medtronic USD 6.52B 400M Apr/2025
Merck USD 12.72B 1.14B Jun/2025
Neurocrine Biosciences USD 595.7M 79.7M Jun/2025
Novartis USD 9.18B 451M Jun/2025
Pacira USD 114.37M 9.62M Jun/2025
Perrigo USD 678.2M 38.6M Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
Regeneron Pharmaceuticals USD 5.61B 49M Jun/2025
Roche Holding CHF 13.46B 984M Dec/2024
Sanofi 8.21B 7.76B Jun/2025
UCB EUR 1.58B 157M Dec/2024
Ultragenyx Pharmaceutical USD 124.46M 25.62M Jun/2025
United Therapeutics USD 379.3M 57.3M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025
Zoetis USD 1.54B 179M Jun/2025